Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases.

Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases. Asian J Androl. 2019 Sep 13;: Authors: Kapoor A, Wong NC, Wang Y, Mukherjee S, Hotte S, Dayes I, Lukka H PMID: 31535625 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31535625?dopt=Abstract

Source: Asian Journal of Andrology - September 12, 2019 Category: Urology & Nephrology Authors: Kapoor A, Wong NC, Wang Y, Mukherjee S, Hotte S, Dayes I, Lukka H Tags: Asian J Androl Source Type: research

More News: Cancer | Cancer & Oncology | Prostate Cancer | Urology & Nephrology